These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapeutic trials using tacrine and other cholinesterase inhibitors. Gamzu ER; Thal LJ; Davis KL Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716 [TBL] [Abstract][Full Text] [Related]
7. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease. Patocka J; Jun D; Kuca K Curr Drug Metab; 2008 May; 9(4):332-5. PubMed ID: 18473751 [TBL] [Abstract][Full Text] [Related]
8. Tacrine and lecithin in Alzheimer's disease. BMJ; 1990 Apr; 300(6729):939-40. PubMed ID: 2337722 [No Abstract] [Full Text] [Related]
9. Tacrine in the treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Summers WK; Tachiki KH; Kling A Eur Neurol; 1989; 29 Suppl 3():28-32. PubMed ID: 2693104 [TBL] [Abstract][Full Text] [Related]
10. THA and Alzheimer's disease. Hayward L; Brodaty H Aust N Z J Psychiatry; 1987 Dec; 21(4):618-9. PubMed ID: 3449055 [No Abstract] [Full Text] [Related]
11. Tacrine in relation to amino acid transmitters in Alzheimer's disease. Bowen DM; Steele JE; Lowe SL; Palmer AM Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197 [No Abstract] [Full Text] [Related]
12. Tetrahydroaminoacridine and Alzheimer's disease. Levy R Lancet; 1987 Feb; 1(8528):322. PubMed ID: 2880126 [No Abstract] [Full Text] [Related]
13. Tacrine in Alzheimer's disease. Davies B; Andrewes D; Stargatt R; Ames D; Tuckwell V; Davis S Lancet; 1989 Jul; 2(8655):163-4. PubMed ID: 2567933 [No Abstract] [Full Text] [Related]